FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323348575> ?p ?o ?g. }

• W4323348575 abstract "Background Microwave ablation (MWA) has achieved favorable results in the treatment of papillary thyroid microcarcinoma (PTMC) confined in glandular parenchyma. However, studies on the outcome of MWA for PTMC with US-detected capsular invasion remain unclarified in the literature. Purpose To compare the feasibility, effectiveness, and safety of MWA in the treatment of PTMC with and without US-detected capsular invasion. Materials and Methods Participants from 12 hospitals with a PTMC maximal diameter of 1 cm or less without US- or CT-detected lymph node metastasis (LNM) who planned to undergo MWA were enrolled in this prospective study between December 2019 and April 2021. All tumors were evaluated with preoperative US and were divided into those with and those without capsular invasion. The participants were observed until July 1, 2022. The primary end points, including technical success and disease progression, and the secondary end points, including treatment parameters, complications, and tumor shrinkage during follow-up, were compared between the two groups, and multivariable regression was performed. Results After exclusion, 461 participants (mean age, 43 years ± 11 [SD]; 337 women) were included: 83 with and 378 without capsular invasion. After one participant with capsular invasion aborted MWA because of technical failure, 82 participants with and 378 participants without capsular invasion (mean tumor volume, 0.1 mL ± 0.1 vs 0.1 mL ± 0.1; P = .07) were analyzed with a mean follow-up period of 20 months ± 4 (range, 12-25 months) and 21 months ± 4 (range, 11-26 months), respectively. In those with and those without capsular invasion, comparable technical success rates were achieved (99% [82 of 83] vs 100% [378 of 378], P = .18), with one and 11 complications, respectively (1% [one of 82] vs 3% [11 of 378], P = .38). There was no evidence of differences in disease progression (2% [one of 82] vs 1% [four of 378]; P = .82) or tumor shrinkage (mean, 97% ± 8 [SD] vs 96% ± 13; P = .58). Conclusion Microwave ablation was feasible in the treatment of papillary thyroid microcarcinoma with US-detected capsular invasion and showed comparable short-term efficacy with or without the presence of capsular invasion. © RSNA, 2023 Clinical trial registration no. NCT04197960 Supplemental material is available for this article." @default.
• W4323348575 created "2023-03-08" @default.
• W4323348575 creator A5005046237 @default.
• W4323348575 creator A5010968399 @default.
• W4323348575 creator A5017496724 @default.
• W4323348575 creator A5024605453 @default.
• W4323348575 creator A5024723836 @default.
• W4323348575 creator A5026507245 @default.
• W4323348575 creator A5037360770 @default.
• W4323348575 creator A5042315486 @default.
• W4323348575 creator A5050975469 @default.
• W4323348575 creator A5052806387 @default.
• W4323348575 creator A5060002817 @default.
• W4323348575 creator A5065172118 @default.
• W4323348575 creator A5066281324 @default.
• W4323348575 creator A5068587614 @default.
• W4323348575 creator A5070537920 @default.
• W4323348575 creator A5076525600 @default.
• W4323348575 creator A5078085986 @default.
• W4323348575 creator A5086477206 @default.
• W4323348575 creator A5088526610 @default.
• W4323348575 creator A5090366405 @default.
• W4323348575 date "2023-05-01" @default.
• W4323348575 modified "2023-10-02" @default.
• W4323348575 title "Microwave Ablation for Papillary Thyroid Microcarcinoma with and without US-detected Capsule Invasion: A Multicenter Prospective Cohort Study" @default.
• W4323348575 cites W1859693723 @default.
• W4323348575 cites W1965985035 @default.
• W4323348575 cites W1992416636 @default.
• W4323348575 cites W2000868171 @default.
• W4323348575 cites W2145150141 @default.
• W4323348575 cites W2281462121 @default.
• W4323348575 cites W2603577764 @default.
• W4323348575 cites W2771013764 @default.
• W4323348575 cites W2801853439 @default.
• W4323348575 cites W2807932048 @default.
• W4323348575 cites W2884883389 @default.
• W4323348575 cites W2966952492 @default.
• W4323348575 cites W2990585145 @default.
• W4323348575 cites W2992714560 @default.
• W4323348575 cites W2999488012 @default.
• W4323348575 cites W2999505261 @default.
• W4323348575 cites W3000116396 @default.
• W4323348575 cites W3014378122 @default.
• W4323348575 cites W3042867714 @default.
• W4323348575 cites W3118296709 @default.
• W4323348575 cites W3126438298 @default.
• W4323348575 cites W3133618441 @default.
• W4323348575 cites W3158830456 @default.
• W4323348575 cites W3173504825 @default.
• W4323348575 cites W3179673543 @default.
• W4323348575 cites W3180667541 @default.
• W4323348575 cites W3187335366 @default.
• W4323348575 cites W4205893890 @default.
• W4323348575 cites W4226372554 @default.
• W4323348575 cites W4283728295 @default.
• W4323348575 doi "https://doi.org/10.1148/radiol.220661" @default.
• W4323348575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36880949" @default.
• W4323348575 hasPublicationYear "2023" @default.
• W4323348575 type Work @default.
• W4323348575 citedByCount "3" @default.
• W4323348575 countsByYear W43233485752023 @default.
• W4323348575 crossrefType "journal-article" @default.
• W4323348575 hasAuthorship W4323348575A5005046237 @default.
• W4323348575 hasAuthorship W4323348575A5010968399 @default.
• W4323348575 hasAuthorship W4323348575A5017496724 @default.
• W4323348575 hasAuthorship W4323348575A5024605453 @default.
• W4323348575 hasAuthorship W4323348575A5024723836 @default.
• W4323348575 hasAuthorship W4323348575A5026507245 @default.
• W4323348575 hasAuthorship W4323348575A5037360770 @default.
• W4323348575 hasAuthorship W4323348575A5042315486 @default.
• W4323348575 hasAuthorship W4323348575A5050975469 @default.
• W4323348575 hasAuthorship W4323348575A5052806387 @default.
• W4323348575 hasAuthorship W4323348575A5060002817 @default.
• W4323348575 hasAuthorship W4323348575A5065172118 @default.
• W4323348575 hasAuthorship W4323348575A5066281324 @default.
• W4323348575 hasAuthorship W4323348575A5068587614 @default.
• W4323348575 hasAuthorship W4323348575A5070537920 @default.
• W4323348575 hasAuthorship W4323348575A5076525600 @default.
• W4323348575 hasAuthorship W4323348575A5078085986 @default.
• W4323348575 hasAuthorship W4323348575A5086477206 @default.
• W4323348575 hasAuthorship W4323348575A5088526610 @default.
• W4323348575 hasAuthorship W4323348575A5090366405 @default.
• W4323348575 hasConcept C126322002 @default.
• W4323348575 hasConcept C141071460 @default.
• W4323348575 hasConcept C188816634 @default.
• W4323348575 hasConcept C2778014663 @default.
• W4323348575 hasConcept C2778778583 @default.
• W4323348575 hasConcept C2778902805 @default.
• W4323348575 hasConcept C2779761222 @default.
• W4323348575 hasConcept C526584372 @default.
• W4323348575 hasConcept C59822182 @default.
• W4323348575 hasConcept C71924100 @default.
• W4323348575 hasConcept C86803240 @default.
• W4323348575 hasConceptScore W4323348575C126322002 @default.
• W4323348575 hasConceptScore W4323348575C141071460 @default.
• W4323348575 hasConceptScore W4323348575C188816634 @default.
• W4323348575 hasConceptScore W4323348575C2778014663 @default.
• W4323348575 hasConceptScore W4323348575C2778778583 @default.
• W4323348575 hasConceptScore W4323348575C2778902805 @default.
• W4323348575 hasConceptScore W4323348575C2779761222 @default.

• next